Randall C. Schatzman, President and CEO at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 9,984 shares at $31.68 ($311K) on 2016-08-01, disclosed to the SEC on 2016-08-03.
Open-market sale of $311k ALDR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.65 | 5,168 | $158K | 50.9% |
| 2 | $31.68 | 4,816 | $153K | 49.1% |
| Total | $31.15 avg | 9,984 | $311K | 100% |
| Filing → |
| ALDR | SELL | 2016-11-09 | $252K | — | Filing → |
| ALDR | SELL | 2016-11-09 | $252K | — | Filing → |
| ALDR | SELL | 2016-10-05 | $255K | — | Filing → |